C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2677723
The invention relates to the use of gene expression profiles for predicting the probability of recurrence or metastases to develop in removed organs of patients from which a primary colon carcinoma has been removed.
L'invention concerne l'utilisation de profils d'expression génique pour la prédiction de la probabilité de l'apparition de récidives ou de métastases dans des organes, ayant subi une résection, de patients ayant subi une résection d'un carcinome primaire du colon.
Adams Hans-Peter
Clevert Djoerk-Arne
Hinzmann Bernd
Mayr Tobias
Shapiro Cohen
Signature Diagnostics Ag
LandOfFree
Prognostic markers for classifying colorectal carcinoma on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prognostic markers for classifying colorectal carcinoma on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prognostic markers for classifying colorectal carcinoma on... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1350190